Hostname: page-component-7c8c6479df-94d59 Total loading time: 0 Render date: 2024-03-19T04:12:49.623Z Has data issue: false hasContentIssue false

Image-based 3D dosimetric studies with high dose rate intracavitary brachytherapy of cervical cancer

Published online by Cambridge University Press:  30 September 2019

N. Chakravarty
Affiliation:
Radiation Oncology Centre, Army Hospital (R&R), Delhi Cantonment, New Delhi110010, India
M. K. Semwal*
Affiliation:
Radiation Oncology Centre, Army Hospital (R&R), Delhi Cantonment, New Delhi110010, India
G. Trivedi
Affiliation:
Radiation Oncology Centre, Army Hospital (R&R), Delhi Cantonment, New Delhi110010, India
V. Suhag
Affiliation:
Radiation Oncology Centre, Army Hospital (R&R), Delhi Cantonment, New Delhi110010, India
M. Jain
Affiliation:
Radiation Oncology Centre, Army Hospital (R&R), Delhi Cantonment, New Delhi110010, India
N. Sharma
Affiliation:
Radiation Oncology Centre, Army Hospital (R&R), Delhi Cantonment, New Delhi110010, India
R. S. Vashisth
Affiliation:
Radiation Oncology Centre, Army Hospital (R&R), Delhi Cantonment, New Delhi110010, India
*
Author for correspondence: Dr M. K. Semwal, Radiation Oncology Centre, Army Hospital (R&R), Delhi Cantonment, New Delhi 110010, India. Tel: +91-11-25691181. Fax: +91-11-25693490. E-mail: manojsemwal@yahoo.co.in

Abstract

Aim:

To study 2D and 3D dosimetric values for bladder and rectum, and the influence of bladder volume on bladder dose in high dose rate (HDR) intracavitary brachytherapy (ICBT). The large patient data incorporated in this study would better represent the inherent variations in many parameters affecting dosimetry in HDR-ICBT.

Material and Methods:

We prospectively collected data for 103 consecutive cervical cancer patients (over 310 HDR fractions) undergoing CT-based HDR-ICBT at our centre. Correlation among bladder and rectum maximum volume doses and corresponding International Commission on Radiation Units and Measurement (ICRU) point doses were estimated and analysed. Impact of bladder volume on bladder maximum dose was assessed.

Results:

The ICRU point doses to bladder and rectum varied from the volumetric doses to these organs. Further, bladder volume poorly correlated with bladder maximum dose for volume variations encountered in the clinical practice at our centre.

Findings:

ICRU point doses to bladder and rectum are less likely to correlate with long-term toxicities to these organs. Further, in clinical practice where inter-fraction bladder volume does not vary widely there is no correlation between bladder volume and bladder dose.

Type
Original Article
Copyright
© Cambridge University Press 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Lindsey, A T, Farhad, I, Rebecca, L S, Elizabeth, M W, Ahmedin, J. Global cancer in women: burden and trends. Cancer Epidemiol Biomarkers Prev 2017; 26 (4): 444457. doi:10.1158/1055-9965.EPI-16-0858.Google Scholar
Sreedevi, A, Javed, R, Dinesh, A. Epidemiology of cervical cancer with special focus on India. Int J Womens Health 2015; 7: 405414.Google Scholar
Green, J A, Kirwan, JM, Tierney, J Fet al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. The Lancet 2001; 358: 781786.CrossRefGoogle Scholar
National Comprehensive Cancer Network. Clinical practice guidelines in oncology: cervical cancer (Version 1.2017). http://www.nccn.org. Accessed on 27th February 2017.Google Scholar
Eifel, P J, Thomas, Jr, W W, Smith, T L, Morris, M, Oswald, M J. The relationship between brachytherapy dose and outcome in patients with bulky endocervical tumors treated with radiation alone. Int J Radiat Oncol Biol Phys 1994; 28: 113118.CrossRefGoogle ScholarPubMed
Ito, H, Kutuki, S, Nishiguchi, Iet al. Radiotherapy for cervical cancer with high-dose rate brachytherapy—correlation between tumor size, dose and failure. Radiother Oncol 1994; 31: 240247.CrossRefGoogle Scholar
Pinkawa, M, Pursch-Lee, M, Asadpour, Bet al. Image-guided radiotherapy for prostate cancer. Strahlenther Onkol 2008; 184: 679685.CrossRefGoogle ScholarPubMed
Gandhi, A K, Sharma, D N, Julka, P, Rath, G K. Attitude and practice of brachytherapy in India: a study based on the survey amongst attendees of Annual Meeting of Indian Brachytherapy Society. J Contemp Brachytherapy 2015; 7 (6): 462468. doi:10.5114/jcb.2015.55666.CrossRefGoogle ScholarPubMed
ICRU Report No. 38. Dose and Volume Specification for Reporting Intracavitary Therapy in Gynecology. Bethesda, MD: International Commission on Radiation Units and Measurements, 1985.Google Scholar
ICRU Report No. 89. Prescribing, Recording, and Reporting Brachytherapy for Cancer of the Cervix. J ICRU. 2013; 13(1&2). International Commission on Radiation Units and Measurements. Oxford: Oxford University Press.Google Scholar
Fellner, C, Pötter, R, Knocke, T H, Wambersie, A. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. Radiother Oncol 2001; 58: 5362.CrossRefGoogle ScholarPubMed
Kim, R Y, Shen, S, Duan, J.Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel. Brachytherapy 2007; 6: 187194.CrossRefGoogle ScholarPubMed
Madan, R, Pathy, S, Subramani, V, et al.Three dimensional computed tomography based dose-volume parameters for high-dose-rate intracavitary brachytherapy of cervical cancer: a prospective study. Asian Pac J of Cancer Prev 2014; 15: 47174721.CrossRefGoogle Scholar
FIGO committee on gynecologic oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet 2009; 105: 103104.CrossRefGoogle Scholar
Karnofsky, D A, Burchenal, J H. The evaluation of chemotherapeutic agents in cancer. In: MacLeod, C M (ed). Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, 1949: 191205.Google Scholar
Onal, C, Arslan, G, Topkan, E, et al. Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses. J Exp Clin Cancer Res 2009; 28: 95. doi:10.1186/1756-9966-28-95.CrossRefGoogle Scholar
Zwahlen, D, Jezeioranski, J, Chan, P, et al. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix. Int J Radiat Oncol Biol Phys 2009; 74: 11571164.CrossRefGoogle ScholarPubMed
Rangarajan, R, Subramanian, S, Gopalakrishnan, K. Comparison between DVH-based doses and ICRU point-based doses to the rectum and the bladder using CT-based high-dose rate brachytherapy to the cervix. Med Dosim 2018; 43: 276283.CrossRefGoogle ScholarPubMed
van den Bergh, F, Meertens, H, Moonen, L, van Bunningen, B, Blom, A. The use of transverse CT image for the estimation of the dose given to the rectum in intracavitary brachytherapy for carcinoma of the cervix. Radiother Oncol 1998; 47: 8590.CrossRefGoogle ScholarPubMed
Barendsen, GW. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 1982; 8: 19811997.CrossRefGoogle Scholar
Mahantshetty, U, Shetty, S, Majumdar, D, et al. Optimal bladder filling during high-dose-rate intracavitary brachytherapy for cervical cancer: a dosimetric study. J Contemp Brachytherapy 2017; 9: 112117.CrossRefGoogle ScholarPubMed
Sun, L M, Huang, H Y, Huang, E Y, et al. A prospective study to assess the bladder distension effects on dosimetry in intracavitary brachytherapy of cervical cancer via computer tomography-assisted techniques. Radiother Oncol 2005; 77: 7782.CrossRefGoogle Scholar
Yamashita, H, Nakagawa, K, Okuma, K, et al. Correlation between bladder volume and irradiated dose of small bowel in CT-based planning of intracavitary brachytherapy for cervical cancer. Jpn J Clin Oncol 2012; 42: 302308.CrossRefGoogle Scholar